These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17604334)

  • 1. Platelet-derived growth factor receptor-alpha: a novel therapeutic target in human hepatocellular cancer.
    Stock P; Monga D; Tan X; Micsenyi A; Loizos N; Monga SP
    Mol Cancer Ther; 2007 Jul; 6(7):1932-41. PubMed ID: 17604334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis.
    Yu JH; Kim JM; Kim JK; Choi SJ; Lee KS; Lee JW; Chang HY; Lee JI
    Oncotarget; 2017 Jun; 8(24):39534-39546. PubMed ID: 28465473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic effects of platelet-derived growth factor receptor α blockade in uterine cancer.
    Roh JW; Huang J; Hu W; Yang X; Jennings NB; Sehgal V; Sohn BH; Han HD; Lee SJ; Thanapprapasr D; Bottsford-Miller J; Zand B; Dalton HJ; Previs RA; Davis AN; Matsuo K; Lee JS; Ram P; Coleman RL; Sood AK
    Clin Cancer Res; 2014 May; 20(10):2740-50. PubMed ID: 24634380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of platelet-derived growth factor receptor alpha promotes tumor progression and indicates poor prognosis in hepatocellular carcinoma.
    Wei T; Zhang LN; Lv Y; Ma XY; Zhi L; Liu C; Ma F; Zhang XF
    Oncotarget; 2014 Nov; 5(21):10307-17. PubMed ID: 25333264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal platelet-derived growth factor receptor α (PDGFRα) provides a therapeutic target independent of tumor cell PDGFRα expression in lung cancer xenografts.
    Gerber DE; Gupta P; Dellinger MT; Toombs JE; Peyton M; Duignan I; Malaby J; Bailey T; Burns C; Brekken RA; Loizos N
    Mol Cancer Ther; 2012 Nov; 11(11):2473-82. PubMed ID: 22933705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis.
    Campbell JS; Johnson MM; Bauer RL; Hudkins KL; Gilbertson DG; Riehle KJ; Yeh MM; Alpers CE; Fausto N
    Differentiation; 2007 Nov; 75(9):843-52. PubMed ID: 17999742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma.
    Govaere O; Petz M; Wouters J; Vandewynckel YP; Scott EJ; Topal B; Nevens F; Verslype C; Anstee QM; Van Vlierberghe H; Mikulits W; Roskams T
    Oncogene; 2017 Nov; 36(47):6605-6616. PubMed ID: 28783171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Pharmacodynamic Biomarker and Mechanistic Modeling Facilitate the Development of Tovetumab, a Monoclonal Antibody Directed Against Platelet-Derived Growth Factor Receptor Alpha, for Cancer Therapy.
    Liang M; Wang B; Schneider A; Vainshtein I; Roskos L
    AAPS J; 2020 Nov; 23(1):4. PubMed ID: 33210183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma.
    Matsuo K; Nishimura M; Komurov K; Shahzad MM; Ali-Fehmi R; Roh JW; Lu C; Cody DD; Ram PT; Loizos N; Coleman RL; Sood AK
    Gynecol Oncol; 2014 Jan; 132(1):166-75. PubMed ID: 24183729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective deletion of hepatocyte platelet-derived growth factor receptor α and development of liver fibrosis in mice.
    Lim BJ; Lee WK; Lee HW; Lee KS; Kim JK; Chang HY; Lee JI
    Cell Commun Signal; 2018 Dec; 16(1):93. PubMed ID: 30509307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet-derived growth factor receptor α by MEDI-575 reduces tumor growth and stromal fibroblast content in a model of non-small cell lung cancer.
    Laing N; McDermott B; Wen S; Yang D; Lawson D; Collins M; Reimer C; Hall PA; Andersén H; Snaith M; Wang X; Bedian V; Cao ZA; Blakey D
    Mol Pharmacol; 2013 Jun; 83(6):1247-56. PubMed ID: 23558446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-derived growth factor receptor alpha (PDGFRα) is overexpressed in NK/T-cell lymphoma and mediates cell survival.
    Lu L; Fu X; Li Z; Qiu Y; Li W; Zhou Z; Xue W; Wang Y; Jin M; Zhang M
    Biochem Biophys Res Commun; 2018 Oct; 504(2):525-531. PubMed ID: 30201265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic target.
    Loizos N; Xu Y; Huber J; Liu M; Lu D; Finnerty B; Rolser R; Malikzay A; Persaud A; Corcoran E; Deevi DS; Balderes P; Bassi R; Jimenez X; Joynes CJ; Mangalampalli VR; Steiner P; Tonra JR; Wu Y; Pereira DS; Zhu Z; Ludwig DL; Hicklin DJ; Bohlen P; Witte L; Kussie P
    Mol Cancer Ther; 2005 Mar; 4(3):369-79. PubMed ID: 15767546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-Derived Growth Factor Receptor α Contributes to Human Hepatic Stellate Cell Proliferation and Migration.
    Kikuchi A; Pradhan-Sundd T; Singh S; Nagarajan S; Loizos N; Monga SP
    Am J Pathol; 2017 Oct; 187(10):2273-2287. PubMed ID: 28734947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role and regulation of PDGFRα signaling in liver development and regeneration.
    Awuah PK; Nejak-Bowen KN; Monga SP
    Am J Pathol; 2013 May; 182(5):1648-58. PubMed ID: 23529017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 2-phenyloxypyrimidine derivative induces apoptosis and autophagy via inhibiting PI3K pathway and activating MAPK/ERK signaling in hepatocellular carcinoma cells.
    Wang J; Sun P; Chen Y; Yao H; Wang S
    Sci Rep; 2018 Jul; 8(1):10923. PubMed ID: 30026540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of platelet-derived growth factor receptor alpha contributes to liver fibrosis.
    Hayes BJ; Riehle KJ; Shimizu-Albergine M; Bauer RL; Hudkins KL; Johansson F; Yeh MM; Mahoney WM; Yeung RS; Campbell JS
    PLoS One; 2014; 9(3):e92925. PubMed ID: 24667490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
    Zhao J; Wozniak A; Adams A; Cox J; Vittal A; Voss J; Bridges B; Weinman SA; Li Z
    J Exp Clin Cancer Res; 2019 Jun; 38(1):252. PubMed ID: 31196136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals.
    Cenciarelli C; Marei HE; Felsani A; Casalbore P; Sica G; Puglisi MA; Cameron AJ; Olivi A; Mangiola A
    Oncotarget; 2016 Aug; 7(33):53047-53063. PubMed ID: 27344175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.